These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32269702)

  • 101. Cisplatin inhibits the growth, migration and invasion of cervical cancer cells by down-regulating IL-17E/IL-17RB.
    Cheng J; Gu CJ; Zhang B; Xie F; Yuan MM; Li MQ; Yu JJ
    Int J Clin Exp Pathol; 2017; 10(9):9341-9351. PubMed ID: 31966806
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Fas regulates the apoptosis and migration of trophoblast cells by targeting NF-κB.
    Lan R; Yang Y; Song J; Wang L; Gong H
    Exp Ther Med; 2021 Oct; 22(4):1055. PubMed ID: 34434269
    [TBL] [Abstract][Full Text] [Related]  

  • 103. AHNAK2 Regulates NF-κB/MMP-9 Signaling to Promote Pancreatic Cancer Progression.
    Tang NN; Xu RB; Jiang B; Zhang HL; Wang XS; Chen DD; Zhu JJ
    Biochem Genet; 2024 Jun; ():. PubMed ID: 38864962
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Signal transducer and activator of transcription 3 signaling upregulates fascin via nuclear factor-κB in gastric cancer: Implications in cell invasion and migration.
    Yao J; Qian CJ; Ye B; Zhao ZQ; Wei J; Liang Y; Zhang X
    Oncol Lett; 2014 Mar; 7(3):902-908. PubMed ID: 24527098
    [TBL] [Abstract][Full Text] [Related]  

  • 105. ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
    Li W; Li S; Yang J; Cui C; Yu M; Zhang Y
    Onco Targets Ther; 2019; 12():3753-3763. PubMed ID: 31190876
    [No Abstract]   [Full Text] [Related]  

  • 106. CD200-CD200R affects cisplatin and paclitaxel sensitivity by regulating cathepsin K-mediated p65 NF-κB signaling in cervical cancer.
    Mou J; Zheng W; Wei D; Li D; Fan R; Tang Q
    Heliyon; 2023 Aug; 9(8):e19220. PubMed ID: 37654464
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Effect of the SIRT3-AMPK/PPAR pathway on invasion and migration of cervical cancer cells.
    Xiao JB; Ma JQ; Yakefu K; Tursun M
    Int J Clin Exp Pathol; 2020; 13(10):2495-2501. PubMed ID: 33165440
    [TBL] [Abstract][Full Text] [Related]  

  • 108. ITIH1 suppresses carcinogenesis in renal cell carcinoma through regulation of the NF‑κB signaling pathway.
    Gao J; Yu G; Yan Y; Hu W; Hu D; Wang W; Yang G; Wei J; Yang S
    Exp Ther Med; 2024 Sep; 28(3):368. PubMed ID: 39091412
    [TBL] [Abstract][Full Text] [Related]  

  • 109.
    Gong Y; Xiang XJ; Feng M; Chen J; Fang ZL; Xiong JP
    Biologics; 2017; 11():45-53. PubMed ID: 28442889
    [No Abstract]   [Full Text] [Related]  

  • 110. MEX3A suppresses proliferation and EMT via inhibiting Akt signaling pathway in cervical cancer.
    Xu Y; Pan S; Chen H; Qian H; Wang Z; Zhu X
    Am J Cancer Res; 2021; 11(4):1446-1462. PubMed ID: 33948367
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Immune Negative Regulator TIPE2 Inhibits Cervical Squamous Cancer Progression Through Erk1/2 Signaling.
    Huang LQ; Zheng B; He Y
    Open Life Sci; 2019 Jan; 14():528-536. PubMed ID: 33817189
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Overexpression of
    Li H; Zhang H; Tan X; Liu D; Guo R; Wang M; Tang Y; Zheng K; Chen W; Li H; Tan M; Wang K; Liu R; Tang S
    Exp Ther Med; 2021 Jul; 22(1):699. PubMed ID: 34007308
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Fyn knockdown inhibits migration and invasion in cholangiocarcinoma through the activated AMPK/mTOR signaling pathway.
    Lyu SC; Han DD; Li XL; Ma J; Wu Q; Dong HM; Bai C; He Q
    Oncol Lett; 2018 Feb; 15(2):2085-2090. PubMed ID: 29434909
    [TBL] [Abstract][Full Text] [Related]  

  • 114. RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway.
    Wang N; Wang J
    Biochem Genet; 2023 Oct; 61(5):2135-2148. PubMed ID: 36952123
    [TBL] [Abstract][Full Text] [Related]  

  • 115. CXCL5 contributes to the tumorigenicity of cervical cancer and is post-transcriptionally regulated by miR-577.
    Bai L; Yao N; Qiao G; Wu L; Ma X
    Int J Clin Exp Pathol; 2020; 13(12):2984-2993. PubMed ID: 33425099
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Dynamin 3 overexpression suppresses the proliferation, migration and invasion of cervical cancer cells.
    Fa J
    Oncol Lett; 2021 Jul; 22(1):524. PubMed ID: 34025791
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Pharmacological targeting transient receptor potential canonical channel 6 modulates biological behaviors for cervical cancer HeLa and SiHA cell.
    Bai LP; Chen YL; Zheng A
    Cancer Cell Int; 2022 Apr; 22(1):145. PubMed ID: 35392906
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Interleukin-17 Promotes Migration and Invasion of Human Cancer Cells Through Upregulation of MTA1 Expression.
    Guo N; Shen G; Zhang Y; Moustafa AA; Ge D; You Z
    Front Oncol; 2019; 9():546. PubMed ID: 31281798
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p65 expression.
    Wang W; Yao S; Jiang H; Dong J; Cui X; Tian X; Guo Y; Zhang S
    Exp Ther Med; 2018 Dec; 16(6):4415-4422. PubMed ID: 30542391
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Influence of icariin on inflammation, apoptosis, invasion, and tumor immunity in cervical cancer by reducing the TLR4/MyD88/NF-κB and Wnt/β-catenin pathways.
    Li C; Yang S; Ma H; Ruan M; Fang L; Cheng J
    Cancer Cell Int; 2021 Apr; 21(1):206. PubMed ID: 33849528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.